NASDAQ: IBACIb Acquisition Corp Stock
$10.80+0.00 (+0%)
Updated Jun 17, 2026
IBAC Price
$10.80
Fair Value Price
N/A
Market Cap
$54.09M
52 Week Low
$10.19
52 Week High
$11.45
P/E
-1,080x
P/B
-32.04x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$986.21k
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.09
Operating Cash Flow
-$2M
Beta
0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
IBAC Overview
IB Acquisition Corp. currently maintains no substantial active business operations. Its primary objective is to identify and execute a business combination, such as a merger, asset acquisition, share exchange, or other strategic corporate reorganization, with one or more target companies located within the United States. The company was founded in 2020 and is headquartered in Boca Raton, Florida.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine IBAC's potential to beat the market
- IBAC doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
IBAC
RankedUnranked of 30
RankedUnranked of 30
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.81 | C | |
| $11.25 | C | |
| $12.39 | C |
Be the first to know about important IBAC news, forecast changes, insider trades & much more!
IBAC News
Overview
Due Diligence Score
–
Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how IBAC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
IBAC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IBAC is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
IBAC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more IBAC due diligence checks available for Premium users.
Valuation
IBAC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1,080x
Industry
15.82x
Market
12.4x
IBAC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-32.04x
Industry
78.19x
IBAC's financial health
Profit margin
Revenue
$0.0
Net Income
-$639.9k
Profit Margin
0%
IBAC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$8.5M
Liabilities
$1.8M
Debt to equity
-1.09
IBAC's short-term liabilities ($1.84M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IBAC's short-term assets ($288.43k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IBAC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IBAC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$265.9k
Investing
$8.0M
Financing
-$7.9M
IBAC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
IBAC vs Shell Company Stocks
Ib Acquisition Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.